|
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) |
|
Mirum Pharmaceuticals Inc
MIRM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Mirum Pharmaceuticals Inc growth rates, revenue grew
by 42.93 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 195
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.99 %
Mirum Pharmaceuticals Inc net loss decreased from $-36 millions, to $-24 millions in IV. Quarter 2024,
• More on MIRM's Growth
|
|
Mirum Pharmaceuticals Inc realized a net loss in trailing twelve months.
Mirum Pharmaceuticals Inc realized cash reduction of $ -1.33 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.53.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on MIRM's Valuation
|
|
|
|
|
Mirum Pharmaceuticals Inc realized net loss in trailing twelve months.
Mirum Pharmaceuticals Inc realized cash outflow of $ -1.33per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.53.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
Mirum Pharmaceuticals Inc Price to Book Ratio is at 9.75 lower than Industry Avg. of 90.03. and higher than S&P 500 Avg. of 0.01
• More on MIRM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com